Clinical trials to test the safety and efficacy of new drugs have a well-known diversity problem.For decades, drug trials have leaned heavily on white male participants, leaving much unknown about how the drugs would work across a wider population.The demographics of clinical trials have changed in recent yearstoday, according to a 2021 study in journal Digital Health, clinical trial participants tend to be older, female, non-Hispanic White, and highly educatedleaving broad swaths of the public out.
#people #information #opportunity #united-states #essentially #requirements #historically #representation #small-number #demographics
[
add
]
[
|
|
...
]